The influence of patients age, type of tumor growth, hematocrit, and radiation-induced tumor regression on the prognosis of advanced uterine cervix carcinoma
Language English Country Slovakia Media print
Document type Comparative Study, Journal Article
PubMed
3185840
Knihovny.cz E-resources
- MeSH
- Adenocarcinoma pathology physiopathology radiotherapy MeSH
- Hematocrit MeSH
- Middle Aged MeSH
- Humans MeSH
- Uterine Cervical Neoplasms pathology physiopathology radiotherapy MeSH
- Follow-Up Studies MeSH
- Actuarial Analysis MeSH
- Prognosis MeSH
- Carcinoma, Squamous Cell pathology physiopathology radiotherapy MeSH
- Neoplasm Staging MeSH
- Age Factors MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
The age of patients, type of tumor growth, pretreatment hematocrit, and radiation-induced tumor regression were evaluated as possible prognostic factors in 222 patients with advanced cervical cancer treated at the Institute of Clinical Oncology in Bratislava in the period from 1960 through 1980. The five-year disease-free survival rate for Stage IIb patients was 50%, for Stage III patients 23.1%, and for Stage IV patients 13%. Radiation-induced tumor regression and type of tumor growth were noted to be a significant prognostic factor with regard to the control of disease in the pelvis. Age of the patients and pretreatment hematocrit were found to be a weak prognostic factor.
